| __timestamp | Incyte Corporation | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 347523000 | 31354781 |
| Thursday, January 1, 2015 | 479514000 | 43445817 |
| Friday, January 1, 2016 | 581861000 | 66489820 |
| Sunday, January 1, 2017 | 1326361000 | 96886134 |
| Monday, January 1, 2018 | 1197957000 | 153793000 |
| Tuesday, January 1, 2019 | 1154111000 | 148369000 |
| Wednesday, January 1, 2020 | 2215942000 | 151934000 |
| Friday, January 1, 2021 | 1458179000 | 198532000 |
| Saturday, January 1, 2022 | 1585936000 | 112128000 |
| Sunday, January 1, 2023 | 1627594000 | 76192000 |
| Monday, January 1, 2024 | 2606848000 |
Unlocking the unknown
In the competitive world of biotechnology, innovation is the lifeblood of success. Incyte Corporation and TG Therapeutics, Inc. have been at the forefront of this race, each investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Incyte consistently outpaced TG Therapeutics, with R&D expenses growing by over 360%, peaking in 2020. In contrast, TG Therapeutics saw a more modest increase of around 140% during the same period.
Incyte's commitment to innovation is evident, with its R&D spending reaching nearly 16 times that of TG Therapeutics by 2023. This substantial investment underscores Incyte's strategic focus on developing groundbreaking therapies. Meanwhile, TG Therapeutics, while smaller in scale, continues to make significant strides in its niche, reflecting a dynamic and evolving biotech landscape.
R&D Insights: How Pfizer Inc. and TG Therapeutics, Inc. Allocate Funds
R&D Insights: How Bristol-Myers Squibb Company and TG Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
BeiGene, Ltd. vs Incyte Corporation: Strategic Focus on R&D Spending
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
R&D Insights: How Incyte Corporation and Amneal Pharmaceuticals, Inc. Allocate Funds
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Incyte Corporation or Vericel Corporation: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Incyte Corporation and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?